Panniculitis Review for the Inpatient Dermatologist

被引:0
|
作者
Glennon, Colleen M. [1 ]
Kroshinsky, Daniela [1 ]
机构
[1] Duke Univ, Sch Med, Dept Dermatol, Durham, NC 27710 USA
来源
CURRENT DERMATOLOGY REPORTS | 2025年 / 14卷 / 01期
关键词
Alpha-1 antitrypsin deficiency-associated panniculitis; Erythema induratum; Erythema nodosum; Pancreatic panniculitis; Polyarteritis nodosa; Lipodermatosclerosis; POLYARTERITIS-NODOSA; ERYTHEMA-NODOSUM; ALPHA-1-ANTITRYPSIN DEFICIENCY; HISTOPATHOLOGIC SPECTRUM; PANCREATIC PANNICULITIS; NODULAR VASCULITIS; CLINICAL SPECTRUM; PATIENT; INFECTION; LUNG;
D O I
10.1007/s13671-025-00464-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Purposeof ReviewPanniculitis presents a diagnostic challenge due to the diverse array of conditions that manifest with a similar clinical picture. Often, these diseases have ties to systemic issues and can be clues to underlying systemic ailments. This article reviews panniculitides pertinent to the inpatient setting, with focus on distinguishing features and approach to diagnosis and management.Recent FindingsErythema nodosum that presents with vasculitis and/or is atypically distributed may serve as a diagnostic clue for underlying systemic disease. Panniculitis may be the presenting sign of alpha-1 antitrypsin deficiency, particularly in patients homozygous for the Pi*Z genotype. Empiric tuberculosis therapy is not recommended in all cases of erythema induratum. Panniculitis may be the presenting feature or sole symptom of pancreatic disease and may signal metastasis in cases associated with pancreatic carcinoma. Genetic susceptibility has been implicated in polyarteritis nodosa.SummaryThe differential diagnosis for classifying panniculitis and for identifying underlying cause is broad. Inpatient dermatologists have an important role in diagnosing panniculitides and in deciphering overall health implications.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist
    Lee, Nari
    Zheng, Lida
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (04) : 222 - 231
  • [32] Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist
    Nari Lee
    Lida Zheng
    Current Dermatology Reports, 2021, 10 : 222 - 231
  • [33] Pseudomonas-Spectrum of Disease Presentations for the Inpatient Dermatologist
    Kye, Yae
    Zhao, Grant
    Nguyen, Cuong V.
    CURRENT DERMATOLOGY REPORTS, 2023, 12 (03) : 115 - 124
  • [34] RICKETTSIOSES - A REVIEW FOR THE DERMATOLOGIST
    BURNETT, JW
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1980, 2 (05) : 359 - 373
  • [35] Systemic Lupus Erythematosus: Considerations in Diagnosis and Management for the Inpatient Dermatologist
    Konstantinov, Nikifor K.
    Pearson, David R.
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (04) : 220 - 230
  • [36] Systemic Lupus Erythematosus: Considerations in Diagnosis and Management for the Inpatient Dermatologist
    Nikifor K. Konstantinov
    David R. Pearson
    Current Dermatology Reports, 2020, 9 : 220 - 230
  • [37] Isotretinoin and the eye: A review for the dermatologist
    Ruiz-Lozano, Raul E.
    Hernandez-Camarena, Julio C.
    Garza-Garza, Lucas A.
    Bustamante-Arias, Andres
    Colorado-Zavala, Maria F.
    Cardenas-de la Garza, Jesus Alberto
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [38] Liver fibrosis for the dermatologist: a review
    Raahimi, Mina M.
    Livesey, Amy
    Hamilton, Jessica
    Shipman, Alexa R.
    Aspinall, Richard J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 303 - 309
  • [39] Panniculitis: a narrative review
    Maniam, Ganesh B.
    Limmer, Emily E.
    Gibson, Lawrence E.
    Tolkachjov, Stanislav N.
    Alavi, Afsaneh
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [40] Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist
    Iulianna Taritsa
    Jennifer N. Choi
    Current Dermatology Reports, 2023, 12 : 225 - 232